Blood filter Face-Off: which GBS treatment wins?
NCT ID NCT04871035
First seen May 07, 2026 · Last updated May 07, 2026
Summary
This study compares two treatments for Guillain-Barré syndrome (GBS), a rare nerve disorder that can cause muscle weakness and paralysis. The two treatments, immunoadsorption and plasma exchange, both filter the blood to remove harmful antibodies. The study will enroll 20 adults with GBS to see which treatment is safer and works better at improving muscle strength and sensation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GBS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Neurology, University of Ulm
RECRUITINGUlm, Baden-Wurttemberg, 89081, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.